BR0009161A - Tratamento de certos cânceres associados a ganho de peso - Google Patents
Tratamento de certos cânceres associados a ganho de pesoInfo
- Publication number
- BR0009161A BR0009161A BR0009161-8A BR0009161A BR0009161A BR 0009161 A BR0009161 A BR 0009161A BR 0009161 A BR0009161 A BR 0009161A BR 0009161 A BR0009161 A BR 0009161A
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- weight gain
- cancer
- cancers associated
- certain cancers
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"TRATAMENTO DE CERTOS CâNCERES ASSOCIADOS A GANHO DE PESO". Um composto de fórmula (I), ou seu sal farmaceuticamente aceitável, em que R~ 1~ e R~ 2~ são independentemente H ou metila (por exemplo, cloridrato de N,N-dimetil-1-[1-(4-clorofenil)ciclobutil]-3-metilbutilamina, opcionalmente na forma de seu monoidrato) é usado para o tratamento de cânceres associados a obesidade, incluindo câncer de cólon, câncer de mama, câncer endometrial e câncer de bexiga.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12525099P | 1999-03-19 | 1999-03-19 | |
PCT/US2000/007361 WO2000056323A1 (en) | 1999-03-19 | 2000-03-17 | Treatment of certain cancers associated with weight gain |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0009161A true BR0009161A (pt) | 2002-01-22 |
Family
ID=22418838
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0009161-8A BR0009161A (pt) | 1999-03-19 | 2000-03-17 | Tratamento de certos cânceres associados a ganho de peso |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1171106A1 (pt) |
JP (1) | JP2002539255A (pt) |
KR (1) | KR20010113765A (pt) |
CN (1) | CN1399545A (pt) |
AU (1) | AU3632000A (pt) |
BG (1) | BG105998A (pt) |
BR (1) | BR0009161A (pt) |
CA (1) | CA2367045A1 (pt) |
CZ (1) | CZ20013281A3 (pt) |
HU (1) | HUP0200497A2 (pt) |
IL (1) | IL145239A0 (pt) |
MX (1) | MXPA01009470A (pt) |
NO (1) | NO20014478L (pt) |
NZ (1) | NZ514012A (pt) |
PL (1) | PL351958A1 (pt) |
SK (1) | SK13372001A3 (pt) |
TR (1) | TR200102692T2 (pt) |
WO (1) | WO2000056323A1 (pt) |
ZA (1) | ZA200107687B (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004096202A1 (en) * | 2003-04-28 | 2004-11-11 | Cipla Limited | Pharmaceutical formulation comprising anti-obesity agent and acidulant |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8531071D0 (en) * | 1985-12-17 | 1986-01-29 | Boots Co Plc | Therapeutic compound |
US5459164A (en) * | 1994-02-03 | 1995-10-17 | Boots Pharmaceuticals, Inc. | Medical treatment |
-
2000
- 2000-03-17 HU HU0200497A patent/HUP0200497A2/hu unknown
- 2000-03-17 CN CN00807533A patent/CN1399545A/zh active Pending
- 2000-03-17 CA CA002367045A patent/CA2367045A1/en not_active Abandoned
- 2000-03-17 AU AU36320/00A patent/AU3632000A/en not_active Abandoned
- 2000-03-17 BR BR0009161-8A patent/BR0009161A/pt not_active Application Discontinuation
- 2000-03-17 TR TR2001/02692T patent/TR200102692T2/xx unknown
- 2000-03-17 MX MXPA01009470A patent/MXPA01009470A/es unknown
- 2000-03-17 CZ CZ20013281A patent/CZ20013281A3/cs unknown
- 2000-03-17 IL IL14523900A patent/IL145239A0/xx unknown
- 2000-03-17 KR KR1020017011855A patent/KR20010113765A/ko not_active Application Discontinuation
- 2000-03-17 PL PL00351958A patent/PL351958A1/xx not_active Application Discontinuation
- 2000-03-17 NZ NZ514012A patent/NZ514012A/xx not_active Application Discontinuation
- 2000-03-17 SK SK1337-2001A patent/SK13372001A3/sk unknown
- 2000-03-17 WO PCT/US2000/007361 patent/WO2000056323A1/en not_active Application Discontinuation
- 2000-03-17 JP JP2000606228A patent/JP2002539255A/ja not_active Withdrawn
- 2000-03-17 EP EP00915015A patent/EP1171106A1/en not_active Withdrawn
-
2001
- 2001-09-14 NO NO20014478A patent/NO20014478L/no unknown
- 2001-09-18 ZA ZA200107687A patent/ZA200107687B/en unknown
- 2001-10-10 BG BG105998A patent/BG105998A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JP2002539255A (ja) | 2002-11-19 |
ZA200107687B (en) | 2002-12-18 |
CA2367045A1 (en) | 2000-09-28 |
EP1171106A1 (en) | 2002-01-16 |
WO2000056323A1 (en) | 2000-09-28 |
BG105998A (en) | 2002-06-28 |
PL351958A1 (en) | 2003-07-14 |
SK13372001A3 (sk) | 2002-07-02 |
TR200102692T2 (tr) | 2002-03-21 |
AU3632000A (en) | 2000-10-09 |
MXPA01009470A (es) | 2004-03-19 |
NZ514012A (en) | 2001-09-28 |
CZ20013281A3 (cs) | 2002-07-17 |
KR20010113765A (ko) | 2001-12-28 |
NO20014478L (no) | 2001-10-29 |
HUP0200497A2 (en) | 2002-08-28 |
IL145239A0 (en) | 2002-06-30 |
NO20014478D0 (no) | 2001-09-14 |
CN1399545A (zh) | 2003-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0210550A (pt) | Método para realçar a eficácia de terapias contra o câncer | |
BR0213233A (pt) | Alcinos inibidores de metaloproteinase de matriz | |
BR0109983A (pt) | Estratrienos substituìdos por 8.beta-hidrocarbila como estrogênios seletivamente eficientes | |
BR0009026A (pt) | Método de tratamento de distúrbio alimentìcio | |
BR0007500A (pt) | Composto triazol, fármaco, e, uso do composto | |
BR0116323A (pt) | Compostos de heterociclilindazol e -azaindazol como ligandos de 5-hidroxitriptamina-6 | |
BRPI0415525A (pt) | derivados de imidazola e seu uso como agentes farmacêuticos | |
BR0212983A (pt) | Composto, uso do composto, e, intermediários de sìntese | |
BR0115102A (pt) | 1-aril- ou 1-alquilsulfonil-heterociclilbenzazóis como ligantes 5-hidroxitriptamina-6 | |
AP1853A (en) | Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents. | |
BR0109703A (pt) | Derivados de piperazina | |
BR0207316A (pt) | Derivados de epotilona para o tratamento de tumores refratários | |
BR0115162A (pt) | Tratamentos antitumorais eficazes | |
BRPI0417158A (pt) | composto, composição farmacêutica, uso de um composto, método para prevenir, tratar ou melhorar uma doença ou condição associada com angiogênese desregulada, e, métodos para tratar ou melhorar cáncer, para reduzir o potencial metastático de um tumor, e para tratar ou melhorar tumores, e uma condição ou doença | |
BR0215016A (pt) | Piridoquinoxalinas antivirìcas | |
BR0113590A (pt) | 7-oxo-piridopirimidinas | |
BRPI0408295A (pt) | uso de um composto | |
BR0206237A (pt) | Uso de um composto de carboestiril | |
BR0211265A (pt) | Derivados de fenilacetamido-tiazol, processo para sua preparação e o seu uso como agentes antitumor | |
BR9711414A (pt) | Processo e composições farmacêuticas para abaixamento do nìvel de ácido úrico no organismo humano e para profilaxia da gota, hiperuricemia ou doença cardìaca coronária em humanos, e, uso de um composto | |
BR0017120A (pt) | Composição farmacêutica | |
NO20023486D0 (no) | Forbindelser av pyrroltypen, perapater inneholdende forbindelser samt deres anvendelse for behandling av cancer- ogvirale sykdommer | |
BR0009161A (pt) | Tratamento de certos cânceres associados a ganho de peso | |
BR0016360A (pt) | Derivados de norbornilamino substituìdos, processos para a sua preparação, seu emprego como medicamento ou diagnóstico bem como medicamento contendo os mesmos | |
GR3031114T3 (en) | Use of a pregnane derivatives for the treatment of tumours. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |